FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Apotex Scientific Duloxetine Delayed-Release Capsules Recall

Duloxetine Delayed-Release Capsules, USP, 20 mg, 60-count bottles, Rx only, Manufacture…

Apotex Scientific, Inc · Arlington, TX

Risk level
Class III
Reported by FDA
Jul 20, 2016
Recall ID
D-1435-2016
Check your lot numberHow we source this data

Summary

Apotex Scientific recalled Duloxetine Delayed-Release Capsules starting Jan 26, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1435-2016 on Jul 20, 2016. Reason: Failed Dissolution Specification: Out of specification dissolution results when testing product stability. Status: Terminated.

Why it was recalled

Failed Dissolution Specification: Out of specification dissolution results when testing product stability.

Product description

Duloxetine Delayed-Release Capsules, USP, 20 mg, 60-count bottles, Rx only, Manufactured by Apotex Inc, Toronto, Ontario M9L 1T9, Manufactured for Apotex Corp. Weston Florida 33326, NDC 60505-2995-6; UPC # 360505299560;

Lot numbers, UPCs & expiration codes

Lot #: KV9795, KV9794, KV9796, KX6278; Exp 04/30/2016.

Where it was sold

Nationwide, Alaska, Hawaii, and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1435-2016
Classification
Class III
Status
Terminated
Recall initiated
Jan 26, 2016
FDA report date
Jul 20, 2016
Quantity
107,880 (60 ct bottle)
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Scientific, Inc

Original FDA data

Every field from FDA enforcement report D-1435-2016, exactly as published.

Show all FDA fields
City
Arlington
State
TX
Status
Terminated
Country
United States
Event ID
73419
Address
2100 Rd To Six Flags Dr
Code information
Lot #: KV9795, KV9794, KV9796, KX6278; Exp 04/30/2016.
Postal code
76011
Report date
Jul 20, 2016
Product type
Drugs
Recall number
D-1435-2016
Classification
Class III
Recalling firm
Apotex Scientific, Inc
Product quantity
107,880 (60 ct bottle)
Termination date
Jun 15, 2022
Reason for recall
Failed Dissolution Specification: Out of specification dissolution results when testing product stability.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Duloxetine Delayed-Release Capsules, USP, 20 mg, 60-count bottles, Rx only, Manufactured by Apotex Inc, Toronto, Ontario M9L 1T9, Manufactured for Apotex Corp. Weston Florida 33326, NDC 60505-2995-6; UPC # 360505299560;
Distribution pattern
Nationwide, Alaska, Hawaii, and Puerto Rico.
Recall initiation date
Jan 26, 2016
Initial firm notification
Letter
Center classification date
Jul 14, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1435-2016, published Jul 20, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls